Monlan, Vanjelyn B.
HRN: 22-45-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/08/2023
01/14/2023
IV
600 Mg
Q8H
CAP-ME
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes